The pharmaceutical industry is a complex sector characterized by significant lobbying power and deep ties to government entities. While it remains a prominent field for investment, the industry frequently faces criticism and public skepticism regarding its motives, including allegations of slowing the development of major medical breakthroughs like a cancer cure. It is often described as an integrated network of large corporations and cartels that exert substantial influence over global healthcare.
“The deal is just a sign of easing pressures on the pharmaceutical industry since the president announced possible future tariffs on drug imports in April.”